November 2016 Br J Cardiol 2016;23:137
BJCardio Staff
Physio-Control, a global leader in lifesaving emergency response technology, is launching a new automated external defibrillator (AED) in European countries (LIFEPAK® CR2). The LIFEPAK® AED Response System: Features a new design intended for ease of use by bystanders and rescuers Launches new technology that supports high quality cardiopulmonary resuscitation Has been demonstrated to offer faster time-to-first-shock Deploys a new remote monitoring and connectivity capability through the online LIFELINKcentral™ AED Program Manager. The CR2 can be remotely monitored and can even, in some areas, transmit a heart rhythm to emergency medical
September 2007 Br J Cardiol 2007;14:242-44
Haroon Siddique, Maria Mushkbar, Adrian Walker, John Scarpello
Introduction Statins are increasingly used for primary and secondary prevention of cardiovascular disease, and in the UK simvastatin is now available as an ‘over-the-counter’ drug without prescription. Rhabdomyolysis is a rare and potentially life-threatening complication of statin therapy and with the wider use of statins there is an increased probability of drug interactions, which may increase the incidence of myopathy and rhabdomyolysis. Early recognition is essential to prevent serious consequences. We report a case of rhabdomyolysis complicated by acute renal failure associated with the concomitant use of high-dose simvastatin and a
April 2002 Br J Cardiol 2002;9:193-4
Anthony S Wierzbicki
No content available
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits